Dr. Vinay Kini, MD

Dr. Kini practices at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital.

Dr. Kini's NPI, 1447453808, was assigned on June 6, 2007. Dr. Kini graduated from Temple University School of Medicine in 2007. Dr. Kini holds New York license 309225.

Dr. Kini's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center, at 525 East 68th Street, New York, NY 10065 in New York County. The practice phone is (212) 746-5454.

Dr. Kini's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital. Dr. Kini is also affiliated with Memorial Sloan Kettering Cancer Center. The medical group on file is Weill Cornell Physicians. Dmand AI also links Dr. Kini to 2 more clinical labs, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kini practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Kini's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Kini's licenses on file in 3 states: New York, Colorado and Pennsylvania.

Dmand AI lists circulation problems, heart attack and heart failure among the conditions Dr. Kini treats.

CMS data shows 1,027 Medicare services from Dr. Kini across 8 procedure codes in 2024, for 854 Medicare patients. Medicare paid $86,211 for them.

CMS counts 854 Medicare patients who saw Dr. Kini in 2024. The largest group is 75 to 84, with 352 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.38, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kini's median patient age at 76, with 47% women.

In 2024, Dr. Kini wrote 29 Medicare Part D claims. 90% of them were for generic drugs. They cover 7 drugs, with $21,454 in total drug cost. In 2020, CMS named 99 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Kini for performance year 2024, reported through an alternative payment model (APM). Dr. Kini accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 40 papers to Dr. Kini, published from 2014 to 2024. 2024 was the busiest year, with 5. The most frequent topics are Medicare, Physicians and Suicide, Assisted. Dr. Kini has published most often in Circ Cardiovasc Qual Outcomes. Dr. Kini's most frequent co-authors are Frederick A. Masoudi, MD, Hillary Day Lum, MD, PhD and Elizabeth Riley Kessler, MD.

CMS Open Payments shows 3 general payments to Dr. Kini from 3 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Braemar Manufacturing, LLC paid the most, $54.

Dr. Kini graduated from Temple University School of Medicine in 2007.

Dr. Kini is in network with 18 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.